Indication
Factor VIII (FVIII) Protein
1 clinical trial
1 product
Product
SPK-8016Clinical trial
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII InhibitorsStatus: Completed, Estimated PCD: 2020-10-14